ACSL3: A Potential Drug Target and Biomarker for Long-chain Acyl-CoA Synthesis

Target Name: ACSL3

NCBI ID: G2181

ACSL3

ACSL3: A Potential Drug Target and Biomarker for Long-chain Acyl-CoA Synthesis

The acyl-coenzyme A (ACA) synthetase is a key enzyme in the synthesis of long-chain fatty acids (LCFAs), which are an essential component of many cell types and are involved in various physiological processes. Long-chain acyl-coenzyme A synthetase (ACSL3) is the rate-limiting enzyme in the synthesis of LCFAs from acyl-CoA, and it has been shown to play a crucial role in the regulation of various cellular processes, including cell growth, differentiation, and metabolism.

Despite its importance, ACSL3 is still an untargeted protein, and its functions and interactions with other molecules are not well understood. Therefore, the identification of potential drug targets and biomarkers for ACSL3 is of great interest.

Drug Targets

1. Chemical Modification of ACSL3

One potential drug target for ACSL3 is the chemical modification of ACSL3, which can lead to changes in its stability, activity, and interactivity with other molecules. The modification of ACSL3 by adding or removing certain amino acids or groups can alter its localization, stability, and interactions with other proteins, making it a potential drug target.

2. ACSL3 as a Metabolite Target

ACSL3 is a metabolite of the amino acid leucine, and leucine has been shown to have various roles in cellular processes, including protein synthesis, DNA replication, and cell signaling. Therefore, targeting ACSL3 as a metabolite of leucine could be a potential drug target.

3. ACSL3 as a Lipid Metabolite Target

ACSL3 is also a metabolite of the amino acid isoleucine, which is involved in the synthesis of various lipids in the cell, including lipoproteins, triacylglycerols, and phospholipids. Therefore, targeting ACSL3 as a lipid metabolite could be a potential drug target for diseases associated with abnormal lipid metabolism, such as cardiovascular disease and metabolic disorders.

4. ACSL3 as a Target for Small Molecule Antibiotics

ACSL3 is also involved in the synthesis of various metabolites, including Ac-CoA, which are potential targets for small molecule antibiotics. Therefore, targeting ACSL3 as a target for small molecule antibiotics could be a potential drug target for various bacterial and fungal infections.

Biomarkers

1. ACSL3 Levels as a Biomarker for Disease

ACSL3 is a critical enzyme in the synthesis of long-chain fatty acids, and alterations in ACSL3 levels or activity can affect the levels of LCFAs in the cell. Therefore, measuring ACSL3 levels in diseases, such as cancer, cardiovascular disease, and metabolic disorders, could be potential biomarkers for these diseases.

2. ACSL3 Activity as a Biomarker for some Neurodegenerative Diseases

ACSL3 is involved in the synthesis of the amino acid leucine, which is involved in the production of neurotransmitters, such as dopamine, in the brain. Therefore, alterations in ACSL3 activity or levels could be potential biomarkers for some neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

3. ACSL3 as a Potential Biomarker for Inflammatory Diseases

ACSL3 is involved in the synthesis of various metabolites, including Ac-CoA, which are involved in the production of inflammatory cytokines. Therefore, targeting ACSL3 as a potential biomarker for inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, is of great interest.

Conclusion

In conclusion, ACSL3 is an important enzyme in the synthesis of long

Protein Name: Acyl-CoA Synthetase Long Chain Family Member 3

Functions: Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation (PubMed:22633490). Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins) (PubMed:18003621). Has mainly an anabolic role in energy metabolism. Mediates hepatic lipogenesis. Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates. Both isoforms exhibit the same level of activity (By similarity)

The "ACSL3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ACSL3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets